-
Fibromyalgia (FDA approved)
-
Major Depression (off label; other SNRI is preferred)
- Unknown safety in Lactation
- Pregnancy Category C
- Milnacipran (Savella) 12.5 mg, 25 mg, 50 mg, 100 mg tablets
- Start: 12.5 mg orally daily for 2-3 days, then
- Next: 12.5 mg orally twice daily for 2-3 days, then
- Next: 25 mg orally twice daily
- Next: May increase to 50 mg orally twice daily
- Maximum: 200 mg/day
- Decrease dose by 50% in severe renal Impairment (eGFR <30 ml/min)
- Olson (2020) Clinical Pharmacology, Medmaster Miami, p. 38-9
- Hamilton (2020) Tarascon Pocket Pharmacopoeia
loading